Lipotropic injections are inappropriate or require careful evaluation in patients with known allergies to any component, uncontrolled medical conditions, significant renal or hepatic impairment, B12-related disorders, or pregnancy and breastfeeding
Alharbi, R
Vitamin B12 (Cobalamin) Critical for neurological function, red blood cell production, and DNA synthesis
Cagrilintide is typically considered for: Adults with BMI 30 , or BMI 27 with a metabolic condition Patients who have plateaued on GLP-1 therapy Individuals with strong appetite, cravings, or binge-eating tendencies Those seeking an alternative to or enhancement of weight loss medications Who Should Avoid Cagrilintide
In support, early clinical data suggests that targeting more than one peptide receptor may promote greater weight loss and cardiovascular benefits than achieved by semaglutide and tirzepatide monotherapy